A Puzzle Doctors Have Noticed for Years
If you care for an older parent with kidney disease, you may have heard something worrying from their doctor. People with chronic kidney disease are more likely to develop Alzheimer's. Not a little more likely — noticeably more.
That link has shown up in study after study. But no one really understood why. Was it shared risk factors like diabetes and high blood pressure? Was the kidney somehow affecting the brain? Or were both just diseases of aging that happened to travel together?
A new paper tried to answer that question by looking at the deepest layer of biology — DNA.
Alzheimer's is one of the most feared diagnoses of old age. Chronic kidney disease is one of the most common. Together, they affect tens of millions of people. If the two conditions share biological machinery, understanding that machinery could one day open doors to better prediction — maybe even better prevention.
This study is the first to look at their shared genetics at a very large scale and across different populations.
The Old Way and the New Twist
Previous studies had asked a simpler question: if you add up all of someone's genetic risk for kidney disease, does it predict their risk for Alzheimer's? The answer was mostly no. The overall genetic correlation between the two conditions was close to zero.
But that hides something important.
The researchers behind this new study argued that looking at the entire genome as one big number misses the story. Two conditions might not track together across all of DNA, yet still share specific hotspots where the same genes matter for both.
So they zoomed in.
Think of the genome as a massive city map. Earlier studies asked, "Are these two neighborhoods alike overall?" — and found no. This new work walked the streets one by one, asking, "Is there a single block where the same house affects both conditions?"
That kind of block is called a pleiotropic locus. Pleiotropy is a ten-dollar word for one gene doing more than one job.
And there are two flavors. Horizontal pleiotropy is when a shared biological pathway affects both conditions from different angles — like a single power outage knocking out both your fridge and your WiFi. Vertical pleiotropy is when one thing actually causes the other — like your fridge failing and your food spoiling.
The distinction matters, because only vertical pleiotropy suggests that fixing one condition might help the other.
The Study Behind the Numbers
The researchers combined genetic data from massive sources. For kidney function, they drew on studies of roughly 1.5 million people of European ancestry and about 145,000 of African ancestry. For late-onset Alzheimer's, they pooled data from hundreds of thousands of European-ancestry participants and about 9,000 people of African ancestry.
Then they layered several modern statistical tools on top — methods that can tease apart whether two conditions share the same DNA variant or just live in the same neighborhood.
Even though the overall genetic correlation was essentially zero, 16 specific hotspots lit up when the researchers looked locally in European-ancestry data. Familiar names showed up. APOE — the most famous Alzheimer's risk gene. PICALM, SPI1, EFTUD1 — names less well known to the public, but important in brain and immune biology.
Most of these hotspots turned out to be horizontal pleiotropy: shared upstream biology, but with different specific variants driving each condition. Not a direct chain reaction.
One variant was different.
The APOE ε4 allele — the single most common genetic risk factor for late-onset Alzheimer's — turned out to be the only variant with shared causality for both kidney function and Alzheimer's. In other words, the same exact DNA change affects both traits.
At two other spots — PICALM and EFTUD1 — the researchers found evidence of vertical pleiotropy, suggesting that kidney-related genetic variants at those specific loci may causally influence Alzheimer's risk down the road.
The Ancestry Gap
Here's the finding that may matter most for the future. Almost none of the European hotspots showed up in the African-ancestry data. Of the 16 pleiotropic loci found in Europeans, only one — APOE — was shared across both ancestry groups.
That's not just a scientific curiosity. Risk prediction tools and future drug targets built mostly on European data will almost certainly work better for some populations than others. Closing that gap requires bigger, more diverse genetic studies — a challenge the field has been slow to meet.
If you or a loved one has chronic kidney disease, this paper does NOT mean treating the kidney will prevent Alzheimer's. It does suggest that the two conditions share real biology at specific spots — enough to take the link seriously as a research direction.
For most people, the practical takeaway is the same as before: manage blood pressure, manage diabetes, stay active, keep kidney function monitored as you age. These habits help both organs anyway.
This is a preprint — posted publicly but not yet peer-reviewed. Most of the genetic data came from European-ancestry populations. The African-ancestry samples were much smaller, meaning real shared loci could have been missed just from lack of statistical power. Genetic associations point at biology; they rarely prove cause directly on their own.
The next step is replication in larger, more diverse samples, and follow-up experiments that test whether the suggested kidney-to-brain pathways at PICALM and EFTUD1 actually play out in real tissue. Meanwhile, the finding that APOE ε4 touches both kidney function and the aging brain adds one more reason to understand this gene in depth.
